Colgate-Palmolive Reports Mixed Q4 Results with Sales Challenges in Key Markets
The company exceeded EPS forecasts but missed revenue expectations, citing foreign exchange headwinds and declining demand in North and Latin America.
- Colgate-Palmolive posted Q4 adjusted earnings per share of $0.91, surpassing analyst estimates, but revenue of $4.94 billion fell short of the $4.97 billion forecast.
- Organic sales growth slowed to 4.3%, hindered by weak demand in North and Latin America and a decline in private label pet nutrition volumes.
- Foreign exchange rates negatively impacted revenue by 4.4%, with Latin America experiencing a 7.2% sales decline, while Europe, APAC, and Africa/Eurasia saw modest growth.
- The company’s FY25 guidance predicts flat revenue growth, factoring in a mid-single-digit negative impact from foreign exchange and a planned exit from private label pet nutrition.
- Despite challenges, analysts view Colgate-Palmolive as a high-quality company, benefiting from market share expansion and increased household penetration.
Benzinga 
Investopedia 
